NCT06549725 2025-08-01
Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening
Lipidica, a.s.
Phase NA Recruiting
Clinical Trials
11 trialsNCT06399419 2024-05-30
CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
Osel, Inc.
Phase 1 Recruiting
NCT04721756 2022-04-25
Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging
Avid Radiopharmaceuticals
Phase EARLY_PHASE1 Unknown
NCT00599755 2018-01-16
Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT02150213 2016-12-05
Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492
Novartis
Phase 2 Completed
NCT00635245 2015-03-11
CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery
Pfizer
Phase 1 Withdrawn
NCT00764621 2014-11-04
Health Economic Evaluation of Primovist-enhanced Liver MRI
Bayer
Phase 4 Completed
NCT00536107 2013-10-01
Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
AstraZeneca
Phase 4 Terminated
NCT01260480 2010-12-17
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Aposense Ltd.
Phase 2 Unknown
NCT00805636 2010-05-12
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Aposense Ltd.
Phase 2 Unknown
NCT00484614 2009-09-03
Study the Role of Positron Emission Mammography in Pre-surgical Planning for Breast Cancer
Naviscan PET Systems
Phase 4 Unknown